Corvino Angela, Frecentese Francesco, Magli Elisa, Perissutti Elisa, Santagada Vincenzo, Scognamiglio Antonia, Caliendo Giuseppe, Fiorino Ferdinando, Severino Beatrice
Department of Pharmacy, School of Medicine, University of Naples Federico II, Via D. Montesano, 49, 80131 Napoli, Italy.
Antioxidants (Basel). 2021 Mar 11;10(3):429. doi: 10.3390/antiox10030429.
Hydrogen sulfide (HS) is an endogenous gasotransmitter recently emerged as an important regulatory mediator of numerous human cell functions in health and in disease. In fact, much evidence has suggested that hydrogen sulfide plays a significant role in many physio-pathological processes, such as inflammation, oxidation, neurophysiology, ion channels regulation, cardiovascular protection, endocrine regulation, and tumor progression. Considering the plethora of physiological effects of this gasotransmitter, the protective role of HS donors in different disease models has been extensively studied. Based on the growing interest in HS-releasing compounds and their importance as tools for biological and pharmacological studies, this review is an exploration of currently available HS donors, classifying them by the HS-releasing-triggered mechanism and highlighting those potentially useful as promising drugs in the treatment of cardiovascular diseases.
硫化氢(HS)是一种内源性气体信号分子,最近已成为健康和疾病状态下众多人类细胞功能的重要调节介质。事实上,大量证据表明硫化氢在许多生理病理过程中发挥着重要作用,如炎症、氧化、神经生理学、离子通道调节、心血管保护、内分泌调节和肿瘤进展。鉴于这种气体信号分子具有众多生理效应,人们对硫化氢供体在不同疾病模型中的保护作用进行了广泛研究。基于对释放硫化氢化合物的兴趣日益增加及其作为生物学和药理学研究工具的重要性,本综述探讨了目前可用的硫化氢供体,根据其释放硫化氢的触发机制对它们进行分类,并强调那些在治疗心血管疾病方面有潜力成为有前景药物的供体。